Clinical Trials
14 trialsNCT03579446 2025-08-03
Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT05017246 2025-07-31
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
Washington University School of Medicine
Phase 2 Terminated
NCT01318161 2021-02-16
EPICOL
Örebro University, Sweden
Phase 3 Terminated
NCT02659501 2021-01-12
Liposomal Bupivacaine in Implant Based Breast Reconstruction
Loma Linda University
Phase NA Terminated
NCT00726830 2020-09-24
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
NCT02591017 2018-11-13
ONKEMI
University Hospital, Basel, Switzerland
Phase 3 Terminated
NCT02044302 2017-04-10
A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction
Yale University
Phase 2 Terminated
NCT02078089 2017-01-31
Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Indiana University
Phase 1 Terminated
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00558870 2016-04-05
Role of Methadone As Co-Opioid Analgesic
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00573937 2016-02-19
Methadone Versus Morphine for Cancer-Related Pain
Mayo Clinic
Phase 2 Terminated
NCT00660348 2014-10-08
Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Terminated
NCT01100437 2012-07-13
Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients
Pfizer
Phase 4 Terminated